Testican 2/SPOCK2 Antibody (327403) [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # FAB2328F
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunoprecipitation, Western Blot
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # 327403
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human Testican 2/SPOCK2
Glu23-Trp424
Accession # Q92563
Glu23-Trp424
Accession # Q92563
Specificity
Detects human Testican 2/SPOCK2 in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human Testican 1 is observed.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for Testican 2/SPOCK2 Antibody (327403) [FITC]
Application
Recommended Usage
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Testican 2/SPOCK2
Alternate Names
KIAA0275, SPOCK2
Gene Symbol
SPOCK2
Additional Testican 2/SPOCK2 Products
Product Documents for Testican 2/SPOCK2 Antibody (327403) [FITC]
Product Specific Notices for Testican 2/SPOCK2 Antibody (327403) [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...